Target intelligence / Profile preview

Messenger RNA capping process

Molecular classification
Other
01

Overview

The messenger RNA capping process (also known as mRNA capping or five-prime capping) is an enzymatic modification occurring co-transcriptionally in eukaryotes, where a specially modified guanine nucleotide (7-methylguanosine) is added via a 5'-5' triphosphate linkage to the 5′ end of nascent pre-mRNA[1][2][3][4][5][6][7][8][9]. This cap structure stabilizes mRNA by protecting it from exonucleolytic degradation, facilitates nuclear export, marks the RNA as "self," and is essential for efficient translation initiation by recruiting ribosomes and translation initiation factors[1][2][3][4][5][7][8][9]. The capping process involves several sequential enzymatic steps: removal of a terminal phosphate by RNA triphosphatase, addition of GMP by guanylyltransferase, and subsequent methylation by methyltransferase[1][4]. This is a fundamental step in eukaryotic gene expression but is not itself a molecular target or biomolecule; rather, the enzymes responsible for capping may be potential therapeutic targets, not the process itself.

Other names
mRNA capping5′ cappingFive-prime capping
02

Biological functions

RNA stabilizationRegulation of gene expressionInitiation of translationProtection from exonuclease degradationNuclear export of mRNA
03

Disease associations

Other (dysregulation can contribute to diseases via altered gene expression, but it is not a primary disease role)

Beyond the preview

Go deeper on Messenger RNA capping process.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Messenger RNA capping process.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call